Skip to content

Clinical trials

Melanoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Country / region: South Korea Clear all

83 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20101
20112
20121
20138
20142
20156
20168
20176
20182
20199
20205
20217
20224
20239
20245
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated22
Active, not recruiting15
Recruiting12
Unknown status4
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Hoffmann-La Roche7
Amgen5
Merck Sharp & Dohme LLC5
Pfizer4
Eli Lilly and Company3
Genentech, Inc.3
Yonsei University3
AstraZeneca2
Bayer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma83
Carcinoma, Non-Small-Cell Lung24
Carcinoma, Renal Cell17
Neoplasms17
Squamous Cell Carcinoma of Head and Neck17
Colorectal Neoplasms16
Breast Neoplasms9
Neoplasm Metastasis8
Ovarian Neoplasms7
Pancreatic Neoplasms7

Trials

Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.